WallStreetZenWallStreetZen

NASDAQ: CMMB
Chemomab Therapeutics Ltd Stock Ownership - Who owns Chemomab Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Chemomab Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George Adi MorChief Executive Officer2026-05-294,878$2.05
$10.00kBuy
George Adi MorChief Executive Officer2026-05-294,926$2.08
$10.25kBuy

1 of 1

CMMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMMB insiders and whales buy or sell their stock.

CMMB Shareholders

What type of owners hold Chemomab Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Access Industries Holdings LLC1.20%6,911,166$13.13MInsider
Gabriel Capital Management Ltd0.87%5,034,150$9.56MInsider
Orbimed Israel GP Ltd0.39%2,241,274$4.26MInsider
George Adi Mor0.19%1,091,698$2.07MInsider
Peter Thiel0.15%877,973$1.67MInsider
Dennison T. Veru0.07%396,540$753.43kInsider
Adar1 Capital Management LLC0.01%80,000$152.00kInstitution
Citadel Advisors LLC0.01%64,182$121.95kInstitution
Kestra Private Wealth Services LLC0.01%61,710$117.25kInstitution
Ikarian Capital LLC0.01%51,793$98.41kInstitution

1 of 3

CMMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMMB0.06%2.91%Net BuyingNet Buying
BLRX0.00%0.39%
PASG4.57%95.43%Net BuyingNet Buying
AIXC0.54%93.56%
INTS4.36%3.92%Net BuyingNet Buying
View Top Biotech Stocks

Chemomab Therapeutics Stock Ownership FAQ

Who owns Chemomab Therapeutics?

Chemomab Therapeutics (NASDAQ: CMMB) is owned by 0.06% institutional shareholders, 2.91% Chemomab Therapeutics insiders, and 97.03% retail investors. Access Industries Holdings LLC is the largest individual Chemomab Therapeutics shareholder, owning 6.91M shares representing 1.20% of the company. Access Industries Holdings LLC's Chemomab Therapeutics shares are currently valued at $13.27M.

If you're new to stock investing, here's how to buy Chemomab Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.